SUBJECTS : Hepatic Oncology | Liver Cancer | Liver Tumour
LATEST MANUSCRIPTS IN Hepatic Oncology
- Alexandra V Kimchy, Harjit Singh, Esha Parikh, Jessica Rosenberg, Kavya Sanghavi, James H Lewis. The predictive value of liver tests for the presence of liver metastases. Hepatic oncology. 2023, 10 (3): HEP48
Cited : 1Read More - Yajing Wang, Zhanqi Wei, Zheng Zhang, Jingyi Xu, Yaqin Wang, Qian Chen, Yuewei Zhang. Hepatic arterial infusion chemotherapy with or without lenvatinib for unresectable cholangiocarcinoma: a single-center retrospective study. Hepatic oncology. 2023, 10 (2): HEP49Cited : 0Read More
- Abdalla Aly, Nicole Fulcher, Brian Seal, Trang Pham, Yunfei Wang, Scott Paulson, Aiwu R He. Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting. Hepatic oncology. 2023, 10 (1): HEP47Cited : 0Read More
- Tasneem Lokhandwala, Abdalla Aly, Eileen Farrelly, Joanne P Willey, Lois E Lamerato, Marcus Healey, Anna D Coutinho, Brian S Seal. Management of hepatocellular carcinoma from diagnosis in routine clinical practice. Hepatic oncology. 2022, 9 (4): HEP45Cited : 0Read More
- Eduardo Crespo, Antonio Hermosín, Álvaro Villalba, Eduardo Daguer, José Flores, Javier Periañez, Mario Martínez-Galdámez, Ernesto Santos. Uncooled TATO microwave system for liver ablation. Hepatic oncology. 2022, 9 (4): HEP46Cited : 0Read More
- Gokula Kumar Appalanaido, Muhamad Zabidi Ahmad, Syadwa Abdul Shukor, Alex Khoo Cheen Hoe, Manisekar K Subramaniam, Ang Soo Fan, Mohd Zahri Abdul Aziz. Pathological complete response with immunotherapy and brachytherapy to 15 metastatic liver lesions in a single patient. Hepatic oncology. 2022, 9 (3): HEP44Cited : 0Read More
- Ellery Altshuler, Mahmoud Aryan, Govind Kallumkal, Hanzhi Gao, Jake Wilson, Ahmed Ouni, Edward De Leo, Wissam Hanayneh, Kelsey Pan. Impact of β-blockers on survival outcomes in patients with unresectable hepatocellular carcinoma. Hepatic oncology. 2022, 9 (2): HEP43Cited : 1Read More
- Giammaria Fiorentini, Donatella Sarti, Michele Nardella, Riccardo Inchingolo, Massimiliano Nestola, Alberto Rebonato, Caterina Fiorentini, Camillo Aliberti, Roberto Nani, Stefano Guadagni. Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases. Hepatic oncology. 2022, 9 (1): HEP40Cited : 2Read More
- Sarah Ronnebaum, Abdalla Aly, Dipen Patel, Fernando Benavente, Juan-David Rueda. Systematic literature review of trials assessing recommended systemic treatments in hepatocellular carcinoma. Hepatic oncology. 2022, 9 (1): HEP41Cited : 2Read More
- Giovanni Brondani Torri, Matheus Dorigatti Soldatelli, Gustavo Felipe Luersen, Caroline Lorenzoni Almeida Ghezzi. Imaging of chemotherapy-induced liver toxicity: an illustrated overview. Hepatic oncology. 2021, 8 (4): HEP32Cited : 2Read More
- Mary Wong, Jong T Kim, Brian Cox, Brent K Larson, Stacey Kim, Kevin M Waters, Eric Vail, Maha Guindi. Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinoma. Hepatic oncology. 2021, 8 (4): HEP39Cited : 8Read More
- Jirapa Chansangrat, Nattawut Keeratibharat. Portal vein embolization: rationale, techniques, outcomes and novel strategies. Hepatic oncology. 2021, 8 (4): HEP42Cited : 11Read More
- Abdalla Aly, Melissa Lingohr-Smith, Jay Lin, Brian Seal. Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA. Hepatic oncology. 2021, 8 (3): HEP37Cited : 0Read More
- Gerardo Tovar-Felice, Andrés García-Gámez, Virgilio Benito-Santamaría, David Balaguer-Paniagua, Jordi Villalba-Auñón, Jaume Sampere-Moragues. Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experience. Hepatic oncology. 2021, 8 (3): HEP38Cited : 2Read More
- Diana Julie Leeming, Signe Holm Nielsen, Roslyn Vongsuvanh, Pruthviraj Uchila, Mette Juul Nielsen, Alexander L Reese-Petersen, David van der Poorten, Mohammed Eslam, Detlef Schuppan, Morten Asser Karsdal, Jacob George. Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinoma. Hepatic oncology. 2020, 8 (2): HEP32Cited : 10Read More
